← Leaderboards
Shawn Patrick Iadonato
Kineta, Inc.
$4,058,443
Attributed
$5,432,136
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2008–20$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,432,136 · 4
By mechanism
R44$4,247,386 · 2
R43$1,184,750 · 2
Top collaborators
- Michael J Gale3 shared
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsCellsImmuneSpecificitySmall MoleculeReceptorLeadRna Virus InfectionsRna VirusesToxic EffectFightingProgramsAgonistPropertyInhibitor/AntagonistAnalogImmune ResponseIn VivoPathway InteractionsDosePre-ClinicalProductionBaseHepatitis C Virus
Grant awards (9)
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics$750,000
R44 · FY2020 · CA · contact PI
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics$750,000
R44 · FY2019 · CA · contact PI
Agonists of the RIG-I Innate Immune Pathway$798,935
R44 · FY2013 · AI · contact PI
Agonists of the RIG-I Innate Immune Pathway$956,404
R44 · FY2012 · AI · contact PI
Agonists of the RIG-I Innate Immune Pathway$992,047
R44 · FY2011 · AI · contact PI
Development of Kv1.3 channel blocker ShK-186 as a therapy for multiple sclerosis$300,000
R43 · FY2011 · AI · contact PI
Development of Kv1.3 channel blocker ShK-186 as a therapy for multiple sclerosis$299,443
R43 · FY2010 · AI · contact PI
Agonists of the RIG-I Innate Immune Pathway$285,415
R43 · FY2009 · AI · contact PI
Agonists of the RIG-I Innate Immune Pathway$299,892
R43 · FY2008 · AI · contact PI